FDA clears Abiomed heart pump after concerns over death rate

Months after federal regulators warned doctors that one of the heart pumps made by Danvers ’ Abiomed could be linked to a higher rate of death than previously thought, the company’s device has been cleared by the FDA. Abiomed (Nasdaq: ABMD) manufactures several small devices that can be inserted into patients’ heart ventricles to pump blood and give the organ’s muscles time to r ecover after a heart attack. The FDA notified doctors in February that it was evaluating a higher-than-previously-observed…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news